These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 22188983
21. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study. Lockwood G, Griesinger G, Cometti B, 13 European Centers. Fertil Steril; 2014 Jan; 101(1):112-119.e3. PubMed ID: 24140033 [Abstract] [Full Text] [Related]
22. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. Engmann L, DiLuigi A, Schmidt D, Benadiva C, Maier D, Nulsen J. Fertil Steril; 2008 Mar; 89(3):554-61. PubMed ID: 17678651 [Abstract] [Full Text] [Related]
23. Vaginal progesterone gel for luteal phase support in IVF/ICSI cycles: a meta-analysis. Polyzos NP, Messini CI, Papanikolaou EG, Mauri D, Tzioras S, Badawy A, Messinis IE. Fertil Steril; 2010 Nov; 94(6):2083-7. PubMed ID: 20171629 [Abstract] [Full Text] [Related]
24. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer. Mui Lam P, Chun Cheung M, Ping Cheung L, Ingrid Lok H, John Haines C. Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535 [Abstract] [Full Text] [Related]
25. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection. Bergh C, Lindenberg S, Nordic Crinone Study Group. Hum Reprod; 2012 Dec; 27(12):3467-73. PubMed ID: 23019296 [Abstract] [Full Text] [Related]
26. Effect of the initiation of progesterone supplementation in in vitro fertilization-embryo transfer outcomes: a prospective randomized controlled trial. Gao J, Gu F, Miao BY, Chen MH, Zhou CQ, Xu YW. Fertil Steril; 2018 Jan; 109(1):97-103. PubMed ID: 29175065 [Abstract] [Full Text] [Related]
27. Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial. Kohls G, Ruiz F, Martínez M, Hauzman E, de la Fuente G, Pellicer A, Garcia-Velasco JA. Fertil Steril; 2012 Oct; 98(4):858-62. PubMed ID: 22749223 [Abstract] [Full Text] [Related]
28. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Chantilis SJ, Zeitoun KM, Patel SI, Johns DA, Madziar VA, McIntire DD. Fertil Steril; 1999 Nov; 72(5):823-9. PubMed ID: 10560985 [Abstract] [Full Text] [Related]
29. Vaginal progesterone gel is non-inferior to intramuscular progesterone in efficacy with acceptable tolerability for luteal phase support: A prospective, randomized, multicenter study in China. Chi H, Li R, Qiao J, Chen X, Wang X, Hao G, Wu Q, Cao Y, Cai L, Ye H, Zhu Y, Wang S, Zhang X, Zhang C, Zhang Y, Lv Q, Sun Y, Li H, Huang X, Wang F. Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():100-105. PubMed ID: 31035117 [Abstract] [Full Text] [Related]
30. [Luteal phase support in assisted reproductive cycles using either vaginal (Crinone 8) or intramuscular (Prontogest) progesterone: results of a prospective randomized study]. Anserini P, Costa M, Remorgida V, Sarli R, Guglielminetti E, Ragni N. Minerva Ginecol; 2001 Aug; 53(4):297-301. PubMed ID: 11431647 [Abstract] [Full Text] [Related]
31. Luteal support for IVF/ICSI cycles with Crinone 8% (90 mg) twice daily results in higher pregnancy rates than with intramuscular progesterone. Ho CH, Chen SU, Peng FS, Chang CY, Yang YS. J Chin Med Assoc; 2008 Aug; 71(8):386-91. PubMed ID: 18772117 [Abstract] [Full Text] [Related]
32. [Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone]. Pouly JL, Bassil S, Frydman R, Hédon B, Nicollet B, Prada Y, Antoine JM, Zambrano R, Donnez J. Contracept Fertil Sex; 1997 Aug; 25(7-8):596-601. PubMed ID: 9410372 [Abstract] [Full Text] [Related]
33. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support. Ludwig M, Finas A, Katalinic A, Strik D, Kowalcek I, Schwartz P, Felberbaum R, Küpker W, Schöpper B, Al-Hasani S, Diedrich K. Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297 [Abstract] [Full Text] [Related]
34. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study. Erdem A, Erdem M, Atmaca S, Guler I. Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788 [Abstract] [Full Text] [Related]
38. Luteal phase support may improve pregnancy outcomes during intrauterine insemination cycles. Maher MA. Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):57-62. PubMed ID: 21514032 [Abstract] [Full Text] [Related]
39. Patient experience in a randomized trial of a weekly progesterone vaginal ring versus a daily progesterone gel for luteal support after in vitro fertilization. Ginsburg ES, Jellerette-Nolan T, Daftary G, Du Y, Silverberg KM. Fertil Steril; 2018 Nov; 110(6):1101-1108.e3. PubMed ID: 30396554 [Abstract] [Full Text] [Related]
40. Vitrified blastocyst transfer cycles with the use of only vaginal progesterone replacement with Endometrin have inferior ongoing pregnancy rates: results from the planned interim analysis of a three-arm randomized controlled noninferiority trial. Devine K, Richter KS, Widra EA, McKeeby JL. Fertil Steril; 2018 Feb; 109(2):266-275. PubMed ID: 29338855 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]